Publisher
Springer Berlin Heidelberg
Reference60 articles.
1. Aagaard-Tillery KM, Jelinek DF (1994) inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin. Cell Immunol 156:493–507.
2. Abraham RT, Wiederrecht GJ (1996) Immunopharmacology of rapamycin. Annu Rev Immunol 14:483–510.
3. Bierer BE, Schreiber SL, Burakoff SJ (1991) The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation. Eur J Immunol 21:439–445.
4. Brattstrom C, Tyden G, Sawe j, Herlenius G, Claesson K, Groth CG (1996) A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients. Transplant Proc 28:985–986.
5. Calne RY, Collier DS, Lim S, Pollard SG, Samaan A, White DJ, Thiru S i 1989) Rapamycin for immunosuppression in organ allografting. Lancet 2:227.